Debt-to-equity of ROCKWELL MEDICAL, INC. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ROCKWELL MEDICAL, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • ROCKWELL MEDICAL, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 70%, a 44% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ROCKWELL MEDICAL, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 70% -56% -44% 30 Sep 2025
Q2 2025 80% -60% -43% 30 Jun 2025
Q1 2025 91% -74% -45% 31 Mar 2025
Q4 2024 108% -75% -41% 31 Dec 2024
Q3 2024 125% -83% -40% 30 Sep 2024
Q2 2024 140% -103% -42% 30 Jun 2024
Q1 2024 165% -53% -24% 31 Mar 2024
Q4 2023 183% -151% -45% 31 Dec 2023
Q3 2023 208% -278% -57% 30 Sep 2023
Q2 2023 243% -361% -60% 30 Jun 2023
Q1 2023 218% -453% -67% 31 Mar 2023
Q4 2022 333% +19% +5.9% 31 Dec 2022
Q3 2022 486% +285% +142% 30 Sep 2022
Q2 2022 604% +458% +315% 30 Jun 2022
Q1 2022 671% +526% +362% 31 Mar 2022
Q4 2021 314% +162% +106% 31 Dec 2021
Q3 2021 201% +47% +30% 30 Sep 2021
Q2 2021 145% -20% -12% 30 Jun 2021
Q1 2021 145% +19% +15% 31 Mar 2021
Q4 2020 152% +41% +37% 31 Dec 2020
Q3 2020 154% +49% +47% 30 Sep 2020
Q2 2020 166% +47% +39% 30 Jun 2020
Q1 2020 127% -8.1% -6% 31 Mar 2020
Q4 2019 111% -5.6% -4.8% 31 Dec 2019
Q3 2019 105% -5.4% -4.9% 30 Sep 2019
Q2 2019 119% 30 Jun 2019
Q1 2019 135% 31 Mar 2019
Q4 2018 117% 31 Dec 2018
Q3 2018 110% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.